Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Magle Chemoswed Holding

4.10 SEK

-2.38 %

Less than 1K followers

MAGLE

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Magle Chemoswed Holding

P/E

Median 2020-2025

EV/S

Median 2020-2021

EV/EBIT

Median 2020-2021

Dividend yield

Median 2020-2025

P/B

Median 2020-2025

 
2019202020212022202320242025
Share price (SEK)-45.7729.7826.7025.1034.8017.60
Shares10.210.010.810.810.818.620.6
Market cap-459.5322.9289.4272.2648.4363.4
Enterprise value-498.2355.4----
EV/S-3.62.7----
EV/EBITDA-30.821.1----
EV/EBIT-110.167.2----
P/E-252.672.729.822.30.8neg.
P/B-3.962.321.971.721.160.92
P/S-3.32.42.01.62.71.3
Dividend yield-0.0 %0.0 %0.0 %1.4 %0.0 %0.0 %
Equity ratio53.5 %58.6 %59.8 %56.7 %56.8 %51.3 %43.5 %
Gearing ratio9.1 %38.6 %26.2 %34.3 %38.1 %62.4 %87.5 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.